Dilemmas In The Diagnosis Of Osteoporosis In Transgender Population
November 2022
in “
Journal of the Endocrine Society
”
TLDR Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.
The document discusses the challenges in diagnosing osteoporosis in the transgender population, particularly in interpreting bone mineral density (BMD) data from DXA scans. It presents three cases of transgender individuals undergoing hormone therapy and highlights discrepancies in BMD results when analyzed according to their assigned gender at birth versus their current gender. The study underscores the lack of clear guidelines for interpreting BMD in transgender patients and the uncertainty about how hormone treatment affects fracture risk. Further research is needed to address these issues.
